Atai Life Sciences Retained Earnings (Accumulated Deficit) 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Atai Life Sciences retained earnings (accumulated deficit) from 2020 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Atai Life Sciences Retained Earnings (Accumulated Deficit) 2020-2024 | ATAI

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$19.5B
Quest Diagnostics (DGX)	$18B
DaVita (DVA)	$12.9B
Encompass Health (EHC)	$10B
Chemed (CHE)	$8.2B
Elanco Animal Health (ELAN)	$6.6B
RadNet (RDNT)	$5.9B
Option Care Health (OPCH)	$3.7B
Amedisys (AMED)	$2.9B
LifeStance Health (LFST)	$2.8B
Astrana Health (ASTH)	$2.3B
Addus HomeCare (ADUS)	$2.2B
U.S Physical Therapy (USPH)	$1.4B
Aveanna Healthcare Holdings (AVAH)	$1.1B
Pennant (PNTG)	$1.1B
Daxor (DXR)	$43M
MEDIROM Healthcare Technologies (MRM)	$15M
Psychemedics (PMD)	$14M
ATI Physical Therapy (ATIP)	$8M
Ontrak (OTRK)	$8M
IMAC Holdings (BACK)	$1M